Insmed (INSM) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $115.07 -2.7%
EPS Growth %: +55.9%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: +55.9%
Financial Fact:
Research and development: 23.43M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.48), in-line with the analyst estimate of ($0.48).
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Barclays upgrades CubeSmart, cuts Public Storage on relative valuation
- What Delta’s report tells investors in American and United
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
